Kaisai Biology: Net profit in the first half of the year was 3.09 billion yuan, a year-on-year increase of 24.74%.

Kaisa Biology released its semi-annual report for the first half of 2025, achieving operating income of 1.671 billion yuan, a year-on-year increase of 15.68%; net profit attributable to shareholders was 309 million yuan, a year-on-year increase of 24.74%. During the reporting period, the company's series of long-chain dicarboxylic acid continued to increase in volume, and sales revenue and gross profit continued to rise, driving the company's operating income, total profit, net profit and other indicators to increase compared to the same period last year.